| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/26/2001 | CN1071759C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and use thereof |
| 09/25/2001 | US6294650 A peptide nucleic acid sequence of six to twenty-five nucleobases which hybridizes to an rna; therapy and detection of cancer |
| 09/25/2001 | US6294518 Anticancer agents |
| 09/25/2001 | US6294062 Method and device for electrochemical immunoassay of multiple analytes |
| 09/25/2001 | CA2110058C Hepatitis c virus (hcv) polypeptides |
| 09/20/2001 | WO2001068871A2 Human phospholipases and polynucleotides encoding the same |
| 09/20/2001 | WO2001068679A2 Peptides targeting specifically tumor-derived endothelial cells |
| 09/20/2001 | WO2001068678A2 Peptides that selectively bind to expanded polyglutamine repeat domains and methods of use thereof |
| 09/20/2001 | WO2001068677A2 Derivatives of breast canacer antigen her-2 for therapeutical use |
| 09/20/2001 | WO2001068676A2 Lhrh-antagonists, production and use thereof as medicament |
| 09/20/2001 | WO2001068145A2 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 09/20/2001 | WO2001068142A1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 09/20/2001 | WO2001068120A2 Uses of bombesin receptor 3 |
| 09/20/2001 | WO2001068115A1 Process for producing peptide sequences possessing anti-hypertension activity |
| 09/20/2001 | WO2000012587A8 Polyamide chains of precise length, methods to manufacture them and their conjugates |
| 09/20/2001 | WO2000009537A3 Compounds having growth hormone releasing activity |
| 09/20/2001 | CA2402936A1 Human phospholipases and polynucleotides encoding the same |
| 09/20/2001 | CA2402721A1 Derivatives of breast cancer antigen her-2 for therapeutical use |
| 09/20/2001 | CA2402327A1 Peptides targeting specifically tumor-derived endothelial cells |
| 09/20/2001 | CA2401873A1 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 09/19/2001 | EP0889901B1 Process and intermediates for the synthesis of lhrh antagonists |
| 09/19/2001 | EP0772630B1 Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same |
| 09/19/2001 | EP0700302B1 Device for treating diabetes mellitus |
| 09/19/2001 | CN1313903A Compound and method for the prevention and/or the treatment of allergy |
| 09/19/2001 | CN1313772A Peptide antagonists of zonulin and methods for use of same |
| 09/19/2001 | CN1071335C Peptide fragments and analogs derived from PBAN1-33 NHz for controlling moths |
| 09/18/2001 | US6291639 Metal-binding cystein-free peptides for diagnostic and therapeutical purposes, methods for their production, and pharmaceuticals containing these compounds |
| 09/18/2001 | US6291430 Mage-3 peptides presented by HLA class II molecules |
| 09/18/2001 | US6291426 Strain of bacillus for controlling plant diseases and corn rootworm |
| 09/18/2001 | US6291183 A plurality of oligonucleotide linker molecules are attached on a planar solid support, photoremovable groups react with terminal ends of oligonucleotides, substrates exposed to light activate binding at selected areas; peptide synthesis |
| 09/18/2001 | CA1341293C Alpha-subunit of the mac-1 leukocyte adhesion receptor |
| 09/13/2001 | WO2001066567A2 Design, synthesis and use of affinity ligands |
| 09/13/2001 | WO2001066147A2 Antimicrobial compounds and formulations |
| 09/13/2001 | WO2001066127A1 Arginine-rich anti-vascular endothelial growth factor peptides that inhibit growth and metastasis of human tumor cells by blocking angiogenesis |
| 09/13/2001 | WO2001028576A3 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY |
| 09/13/2001 | CA2400410A1 Antimicrobial compounds and formulations |
| 09/12/2001 | EP1132471A2 TNF-binding proteins |
| 09/12/2001 | EP1132394A1 Stable analogs of bioactive peptides containing disulfide linkages |
| 09/12/2001 | EP1131464A1 Method for screening for substances which are activators, inhibitors or binders of pkb by the use of a substrate peptide and the use of the substrate peptide |
| 09/12/2001 | EP1131436A1 Urotensins ii of mammals and their uses |
| 09/12/2001 | EP1131426A2 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides |
| 09/12/2001 | EP1131352A2 Rantes-derived peptides with anti-hiv activity |
| 09/12/2001 | EP1131351A2 Peptides that modulate the interaction of b class ephrins and pdz domains |
| 09/12/2001 | EP1131348A1 Regulatory/unfolding peptides of ezrin |
| 09/12/2001 | EP1131344A2 Retro-inversion peptides that target git transport receptors and related methods |
| 09/12/2001 | EP1131342A1 Compositions and methods for controlling plant pests |
| 09/12/2001 | EP1049481A4 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
| 09/12/2001 | EP1012741A4 Small molecule mimetics of erythropoietin |
| 09/12/2001 | EP0822826B1 Nitrosylated neuropeptides |
| 09/12/2001 | EP0808326B1 Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics |
| 09/12/2001 | EP0804452B1 Recombinant c140 receptor, its agonists and antagonists |
| 09/12/2001 | EP0781348B1 Process for manufacturing cyclosporin a by highly productive fusant strain |
| 09/12/2001 | EP0766736B1 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 09/12/2001 | EP0586474B1 Peptide nucleic acids |
| 09/12/2001 | CN1312817A Dolastatin 15 derivatives |
| 09/12/2001 | CN1312724A TNF-drvived peptides of use in treating oedema |
| 09/12/2001 | CN1312723A Compound and method for diagnosis of tuberculosis |
| 09/12/2001 | CN1070868C Peptides as therapeutic agents for treatment of auto-immune diseases |
| 09/11/2001 | US6288055 Analgesic agents |
| 09/11/2001 | US6288037 C-terminally modified pentapeptides containing valine and aspartic acid |
| 09/11/2001 | US6288036 Bradykinin type peptides |
| 09/11/2001 | US6288029 Template assembled synthetic peptide effective to treat respiratory system disorders |
| 09/11/2001 | US6288028 BPC peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
| 09/11/2001 | US6287792 Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology |
| 09/11/2001 | US6287761 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 09/11/2001 | CA2125175C New peptide derivatives |
| 09/11/2001 | CA2023194C Peptides having bradykinin antagonist action |
| 09/07/2001 | WO2001064745A1 A novel polypeptide, a human beta-preprotachykinin 12 and the polynucleotide encoding the polypeptide |
| 09/07/2001 | WO2001064738A2 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | WO2001064716A1 Antiviral compounds |
| 09/07/2001 | WO2001064234A1 Casein derived peptides and uses thereof in therapy |
| 09/07/2001 | WO2001064008A2 Vaccine for the treatment of artherosclerosis |
| 09/07/2001 | WO2001016163A3 Peptide mixture and vaccine against a chronic viral infection |
| 09/07/2001 | WO2001016160A3 Purification and analysis of cyclic peptide libraries, and compositions thereof |
| 09/07/2001 | WO2000047618A3 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES |
| 09/07/2001 | CA2689666A1 Heterologous expression of neisserial proteins |
| 09/07/2001 | CA2401755A1 Vaccine for the treatment of artherosclerosis |
| 09/07/2001 | CA2401613A1 Amino acids sequencing facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | CA2401550A1 Casein derived peptides and uses thereof in therapy |
| 09/06/2001 | WO2001064715A2 Memno peptides, a process for their preparation and their use |
| 09/05/2001 | EP1130388A1 Improved sensor membranes |
| 09/05/2001 | EP1130387A1 Linker lipid for sensor membranes |
| 09/05/2001 | EP1130386A1 Improved sensor membranes |
| 09/05/2001 | EP1130027A1 Memno peptides, process for preparation and use thereof |
| 09/05/2001 | EP1129718A2 Therapeutic uses of bactericidal/permeability increasing protein products |
| 09/05/2001 | EP1129181A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 09/05/2001 | EP1129112A2 Peptides containing a cholesterol recognition sequence and their uses |
| 09/05/2001 | EP1067950A4 Neo-tryptophan |
| 09/05/2001 | EP0956029A4 Cyclic peptides having broad spectrum antimicrobial activity |
| 09/05/2001 | EP0832107B1 An improved peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone lhrh, and analogs of the lhrh tandem repeat peptide and their use as vaccine |
| 09/05/2001 | CN1311796A Peptide antiangiogenic drugs |
| 09/05/2001 | CN1311794A Aerothricin analogs, their prepn. and use |
| 09/05/2001 | CN1311241A New polypeptide-human beta preprotachykinin 12 and polynucleotide for coding such polypeptide |
| 09/05/2001 | CN1311208A New polypeptide-human beta-pre-protachy kinin 9 and polynucleotide for coding said polypeptide |
| 09/04/2001 | US6284733 Polypeptides |
| 09/04/2001 | US6284476 Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individuals |
| 09/04/2001 | US6284454 Variant of LAV viruses |
| 08/30/2001 | WO2001062777A1 Bombesin analogs for treatment of cancer |
| 08/30/2001 | WO2001062776A1 Hla binding peptides and their uses |
| 08/30/2001 | WO2001062775A2 Novel antiarrhythmic peptides |